Your browser doesn't support javascript.
loading
Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023.
Joshi, Monika; Tuanquin, Leonard; Zhu, Junjia; Walter, Vonn; Schell, Todd; Kaag, Matthew; Kilari, Deepak; Liao, Jiangang; Holder, Sheldon L; Emamekhoo, Hamid; Sankin, Alexander; Merrill, Suzzane; Zheng, Hong; Warrick, Joshua; Hauke, Ralph; Gartrel, Benjamin; Stein, Mark; Drabick, Joseph; Degraff, David J; Zakharia, Yousef.
Affiliation
  • Joshi M; Department of Medicine, Penn State Cancer Institute, Hershey, Pennsylvania, USA mjoshi@pennstatehealth.psu.edu.
  • Tuanquin L; Department of Radiation Oncology, Penn State Cancer Institute, Hershey, Pennsylvania, USA.
  • Zhu J; Public Health Sciences, Penn State Cancer Institute, Hershey, Pennsylvania, USA.
  • Walter V; Public Health Sciences, Penn State Cancer Institute, Hershey, Pennsylvania, USA.
  • Schell T; Microbiology and Immunology, Penn State Cancer Institute, Hershey, Pennsylvania, USA.
  • Kaag M; Department of Surgery, Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, USA.
  • Kilari D; Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Liao J; Public Health Sciences, Penn State Cancer Institute, Hershey, Pennsylvania, USA.
  • Holder SL; Department of Medicine, Penn State Cancer Institute, Hershey, Pennsylvania, USA.
  • Emamekhoo H; Department of Medicine, University of Wisconsin-Madison Carbone Cancer Center, Madison, Wisconsin, USA.
  • Sankin A; Department of Urology, Montefiore Medical Center, Bronx, New York, USA.
  • Merrill S; Department of Surgery, Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, USA.
  • Zheng H; Department of Medicine, Penn State Cancer Institute, Hershey, Pennsylvania, USA.
  • Warrick J; Pathology, Penn State Health Milton S Hershey Medical Center, Hershey, Pennsylvania, USA.
  • Hauke R; Nebraska Cancer Specialists, Omaha, Nebraska, USA.
  • Gartrel B; Department of Urology, Montefiore Medical Center, Bronx, New York, USA.
  • Stein M; Department of Medicine, Montefiore Medical Center, Bronx, New York, USA.
  • Drabick J; Department of Medicine, Columbia University/Herbert Irving Cancer Center, New York, New York, USA.
  • Degraff DJ; Department of Medicine, Penn State Cancer Institute, Hershey, Pennsylvania, USA.
  • Zakharia Y; Department of Pathology, Penn State College of Medicine, Hershey, Pennsylvania, USA.
J Immunother Cancer ; 11(2)2023 02.
Article in En | MEDLINE | ID: mdl-36822667
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / B7-H1 Antigen / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Humans Language: En Journal: J Immunother Cancer Year: 2023 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / B7-H1 Antigen / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Humans Language: En Journal: J Immunother Cancer Year: 2023 Document type: Article Affiliation country: United States